Supported by an unrestricted educational grant from Allergan.
Upon completion of this activity, the participant should be able to:
ACCREDITATION STATEMENT
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Evolve Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsored by:
Evolve is an approved COPE Administrator.
This course is COPE approved for 1.0 hour of CE credit for optometrists.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Earl Randy Craven, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Aqueous Biomedical, Gore, Haag-Streit, Ivantis, and Santen. Grant Research Support: Allergan, Gore, and Haag-Streit.
Preeya K. Gupta, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Aurea, Bausch + Lomb, Carl Zeiss Meditec, Dompe, Eye Point Pharmaceuticals, Johnson & Johnson Vision, Kala, NovaBay Pharmaceuticals, Novartis, Ocular Science, Oyster Point Pharmaceuticals, and TearLab.
Nathan M. Radcliffe, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Aerie Pharmaceuticals, Alcon, Alimera Sciences, Allergan, Bausch + Lomb, Carl Zeiss Meditec, CATS, Ellex, Endo Optiks, Equinox, Glaukos, Iridex, Ivantis, Lumenis, New World Medical, Novartis, Ocular Science, Omeros, Reichert Technologies, Shire, and Sight Sciences.
Robert N. Weinreb, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, Eyenovia, Galimedix, Genentech, Implandata, Quark, Sensimed, and Unity Biosciences. Speaker’s Bureau: Aerie Pharmaceuticals, Carl Zeiss Meditec, Centervue, Genentech, Haag-Streit, Heidelberg Engineering, Konan, Lumenis, National Eye Institute, Optos, Optovue, Quark, Tomey, and Topcon. Intellectual Rights: Toromedes. Patent Holder: Carl Zeiss Meditec and Toromedes.
EDITORIAL SUPPORT DISCLOSURES
Erin K. Fletcher, MIT, director of compliance and education; Susan Gallagher-Pecha, director of client services and project management; Cassandra Richards, director of education development, Evolve; and Virginia Pickles, writer, have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Glaucoma Today, Modern Optometry, or Allergan.
